Being human: ASHG 2012 annual meeting preview

American Society for Human Genetics delves into specifics of human genome in San Francisco
| 11 min read
Written byJeffrey Bouley
SAN FRANCISCO—The human genome starsaligned well for this issue of ddn, allowing us not only tocover major news with initial results from the Encyclopedia of DNAElements (ENCODE) project—showing that much of our human junk DNAisn't junk after all (see October 2012 cover story, "Treasure in thejunk")—but also to have that happen in the same issue we previewwhat is reportedly the largest human genetics meeting and expositionin the world.
Hosted in the "City by the Bay"this year, the American Society of Human Genetics (ASHG) will holdits 62nd annual meeting Nov. 6-10 at San Francisco's MosconeCenter, with more than 6,000 scientists, medical geneticists andgenetic counselors expected to attend and more than 200 companies setto grace the exhibit hall. The meeting headquarters is the SanFrancisco Marriott Marquis Hotel.
The ASHG meeting's scientificsessions, platform presentations and posters will cover a number ofareas, prime among them being gene discovery in human genetics, newinsights and challenges in next-generation sequencing, revelationsabout human genes from studies of model organisms, progress in genetherapy, advances in non-invasive prenatal diagnosis, implications ofpopulation genetic studies, modeling in statistical genetics, datacentralization and its implications for genetics, cancer genetics,clinical and social implications of genomics and improvements ingenetics education.
The meeting also will featurepresentations of ASHG's annual awards (see "Briefs" stories after this article) and the Gruber Genetics Prize.
"Whole-genome and whole-exomesequencing occupy a dominant place in this year's program," Dr.Michael J. Dougherty, ASHG's director of education, tells ddn."These technologies, made possible by rapid increases in sequencingcapacity and bioinformatics and dramatic decreases in cost, areenabling breakthroughs in the discovery of disease genes and theidentification of biological pathways that may be good targets fortherapeutics. Also, this year the ASHG meeting will highlight theextent and importance of rare variation and unprecedented levels ofinternational collaboration via large consortia."
Also, in the realm of public outreach,the ASHG 2012 meeting will host for the first time its Science Café,with the topic being the genetics of autism, he says.
Dr. Mary-Claire King, ASHG presidentand professor of genome sciences and medicine at University ofWashington-Seattle, will kick-off the conference on Tuesday, Nov. 6,with the topic, "The Scientist as a Citizen of the World," withthe meeting capped off by its closing symposium on Saturday, whichwill be "Present and Future Directions for Human Genetics."
The rapidly changing landscape of humangenetic research has brought with it significant changes for ASHG'sannual meeting, Dougherty notes, saying, "With the rise oftechnologies that allow genomic-scale investigations and thegeneration of large datasets, bioinformatics tools have become anessential part of genetic analysis. In recent years, ASHG hasdramatically increased the number of training workshops involvingbioinformatics tools, such as the UCSC Browser, Galaxy and Ensembl.These workshops are one example of how ASHG supports the professionaldevelopment of its trainees, who are particularly eager consumers ofthese tools, and how it supports the advancement of the researchenterprise itself."
Beyond the knowledge-gaining aspect ofthe show, Dougherty adds that since just 2009, the annual meeting hasgrown from 4,800 scientific registrants to 6,300 and from a 189-boothshow to a 300-booth show. Compared to previous years, registrationand vendor booth sales are up, Dougherty shares, noting that ASHGexpects to sell out booth space—300 booths in total and 210companies among them—and was already at 5,250 scientificregistrants by late September, with an expectation to match or exceedthe group's 2011 record of 6,345 registrants.
New for the 2012 conference will be amobile app related to the show.
"In the past, we've had a mobilewebsite, but this is the first year we're taking advantage of thewidespread use of smart phones to deploy a downloadable mobile app,"Dougherty explains. "We believe this will greatly enhance ourattendees' ability to navigate the meeting and obtain even morevalue from their attendance."
That addition, and the rapid growth ofthe meeting in recent years, probably won't be the only changes tocome soon.
To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A syringe positioned horizontally above a small vial labeled “cancer vaccine” against a solid purple background.
Rapid DNA-to-mRNA workflows help scientists keep pace with rapidly evolving cancer through personalized vaccines. 
Futuristic 3D human figure surrounded by medical technology and data visuals.
Understand how a human-relevant in vitro model can be used to improve next generation risk assessment (NGRA).
Point-cloud style digital liver illustration with branching vessels on a dark teal background.
Explore the role of microphysiological systems in advancing human-relevant liver toxicity testing and mechanistic evaluation.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue